Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value: $2.755B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GHRS | GH RESEARCH PLC | 9,275,158 | $216M | 7.9% | — | — | ORDINARY SHARES | G3855L106 |
| KYMR | KYMERA THERAPEUTICS INC | 3,180,658 | $202M | 7.3% | — | — | COM | 501575104 |
| RCUS | ARCUS BIOSCIENCES INC | 3,398,067 | $138M | 5.0% | — | — | COM | 03969F109 |
| — | MERUS N V | 4,135,071 | $131M | 4.8% | — | — | COM | N5749R100 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 3,651,759 | $125M | 4.5% | — | — | COM | 74366E102 |
| XENE | XENON PHARMACEUTICALS INC | 3,289,540 | $103M | 3.7% | — | — | COM | 98420N105 |
| — | REPARE THERAPEUTICS INC | 4,858,761 | $102M | 3.7% | — | — | COM | 760273102 |
| RLAY | RELAY THERAPEUTICS INC | 3,130,605 | $96.14M | 3.5% | — | — | COM | 75943R102 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 3,003,879 | $85.34M | 3.1% | — | — | COM | 22663K107 |
| CGEM | CULLINAN ONCOLOGY INC | 5,369,459 | $82.85M | 3.0% | — | — | COM | 230031106 |
| ARGX | ARGENX SE | 216,204 | $75.71M | 2.7% | — | — | SPONSORED ADR | 04016X101 |
| XOMA | XOMA CORP DEL | 3,530,543 | $73.61M | 2.7% | — | — | COM NEW | 98419J206 |
| OLMA | OLEMA PHARMACEUTICALS INC | 7,411,503 | $69.37M | 2.5% | — | — | COM | 68062P106 |
| GLPG | GALAPAGOS NV | 1,156,393 | $63.75M | 2.3% | — | — | SPON ADR | 36315X101 |
| LXRX | LEXICON PHARMACEUTICALS INC | 14,360,000 | $56.58M | 2.1% | — | — | COM NEW | 528872302 |
| — | AMARIN CORP PLC | 16,459,965 | $55.47M | 2.0% | — | — | SPONS ADR NEW | 023111206 |
| — | EQRX INC | 7,859,670 | $53.6M | 1.9% | — | — | COM | 26886C107 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,099,714 | $45.96M | 1.7% | — | — | COM | 87164F105 |
| RVMD | REVOLUTION MEDICINES INC | 1,810,549 | $45.57M | 1.7% | — | — | COM | 76155X100 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 2,005,862 | $44.01M | 1.6% | — | — | COM | 35104E100 |
| — | ESSA PHARMA INC | 2,851,461 | $40.49M | 1.5% | — | — | COM NEW | 29668H708 |
| — | RAIN THERAPEUTICS INC | 2,957,807 | $38.1M | 1.4% | — | — | COM | 75082Q105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,879,412 | $37.16M | 1.3% | — | — | COM | 92790C104 |
| RLMD | RELMADA THERAPEUTICS INC | 1,647,400 | $37.12M | 1.3% | — | — | COM | 75955J402 |
| — | VERASTEM INC | 17,062,158 | $34.98M | 1.3% | — | — | COM | 92337C104 |
| ACIU | AC IMMUNE SA | 7,062,379 | $34.96M | 1.3% | — | — | SHS | H00263105 |
| — | CHINOOK THERAPEUTICS INC | 1,800,000 | $29.36M | 1.1% | — | — | COM | 16961L106 |
| KURA | KURA ONCOLOGY INC | 2,064,212 | $28.9M | 1.0% | — | — | COM | 50127T109 |
| TYRA | TYRA BIOSCIENCES INC | 1,873,332 | $26.36M | 1.0% | — | — | COM | 90240B106 |
| SPRO | SPERO THERAPEUTICS INC | 1,585,615 | $25.39M | 0.9% | — | — | COM | 84833T103 |
| CTMX | CYTOMX THERAPEUTICS INC | 5,803,700 | $25.13M | 0.9% | — | — | COM | 23284F105 |
| REPL | REPLIMUNE GROUP INC | 926,529 | $25.11M | 0.9% | — | — | COM | 76029N106 |
| ACRS | ACLARIS THERAPEUTICS INC | 1,695,904 | $24.66M | 0.9% | — | — | COM | 00461U105 |
| — | IKENA ONCOLOGY INC | 1,798,371 | $22.55M | 0.8% | — | — | COM | 45175G108 |
| — | CTI BIOPHARMA CORP | 8,929,690 | $22.15M | 0.8% | — | — | COM | 12648L601 |
| — | ALPINE IMMUNE SCIENCES INC | 1,589,495 | $22.02M | 0.8% | — | — | COM | 02083G100 |
| WHWK | AADI BIOSCIENCES INC | 899,392 | $21.72M | 0.8% | — | — | COM | 00032Q104 |
| OVID | OVID THERAPEUTICS INC | 6,631,051 | $21.29M | 0.8% | — | — | COM | 690469101 |
| — | PIERIS PHARMACEUTICALS INC | 5,328,239 | $20.14M | 0.7% | — | — | COM | 720795103 |
| JANX | JANUX THERAPEUTICS INC | 1,017,314 | $20.07M | 0.7% | — | — | COM | 47103J105 |
| PYXS | PYXIS ONCOLOGY INC | 1,791,351 | $19.65M | 0.7% | — | — | COMMON STOCK | 747324101 |
| — | CALLIDITAS THERAPEUTICS AB | 750,000 | $18.57M | 0.7% | — | — | SPONSERED ADS | 13124Q106 |
| — | NGM BIOPHARMACEUTICALS INC | 955,000 | $16.91M | 0.6% | — | — | COM | 62921N105 |
| — | POINT BIOPHARMA GLOBAL INC | 2,920,526 | $16.36M | 0.6% | — | — | COM | 730541109 |
| SLN | SILENCE THERAPEUTICS PLC | 666,666 | $15.6M | 0.6% | — | — | ADS | 82686Q101 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 6,353,645 | $14.3M | 0.5% | — | — | COM | 45665G303 |
| — | SUTRO BIOPHARMA INC | 925,148 | $13.77M | 0.5% | — | — | COM | 869367102 |
| — | GLYCOMIMETICS INC | 9,544,262 | $13.74M | 0.5% | — | — | COM | 38000Q102 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 809,282 | $13.64M | 0.5% | — | — | COM | 23954D109 |
| COGT | COGENT BIOSCIENCES INC | 1,532,282 | $13.15M | 0.5% | — | — | COM | 19240Q201 |
| — | VIRACTA THERAPEUTICS INC | 3,438,944 | $12.55M | 0.5% | — | — | COM | 92765F108 |
| — | MOLECULAR TEMPLATES INC | 3,129,599 | $12.27M | 0.4% | — | — | COM | 608550109 |
| — | CONTRAFECT CORP | 3,972,300 | $10.45M | 0.4% | — | — | COM NEW | 212326300 |
| — | ELEVATION ONCOLOGY INC | 1,611,698 | $9.702M | 0.4% | — | — | COM | 28623U101 |
| — | MEI PHARMA INC | 3,532,057 | $9.431M | 0.3% | — | — | COM NEW | 55279B202 |
| — | CIDARA THERAPEUTICS INC | 6,861,127 | $8.714M | 0.3% | — | — | COM | 171757107 |
| MOLN | MOLECULAR PARTNERS AG | 443,221 | $8.55M | 0.3% | — | — | ADS | 60853G106 |
| NUVL | NUVALENT INC | 448,512 | $8.54M | 0.3% | — | — | COM | 670703107 |
| IVA | INVENTIVA SA | 544,500 | $7.438M | 0.3% | — | — | ADS | 46124U107 |
| — | CONCERT PHARMACEUTICALS INC | 2,253,000 | $7.097M | 0.3% | — | — | COM | 206022105 |
| MIRM | MIRUM PHARMACEUTICALS INC | 435,936 | $6.953M | 0.3% | — | — | COM | 604749101 |
| ELDN | ELEDON PHARMACEUTICALS INC | 1,378,020 | $6.077M | 0.2% | — | — | COM | 28617K101 |
| — | SELECTA BIOSCIENCES INC | 1,723,133 | $5.617M | 0.2% | — | — | COM | 816212104 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 454,545 | $5.118M | 0.2% | — | — | SPONSORED ADS | 152309100 |
| — | EUCRATES BIOMEDICAL ACQU COR | 500,000 | $4.99M | 0.2% | — | — | UNIT 10/23/2027 | G3141W114 |
| — | CALITHERA BIOSCIENCES INC | 7,452,331 | $4.957M | 0.2% | — | — | COM | 13089P101 |
| — | FRAZIER LIFESCIENCES ACQU CO | 500,000 | $4.95M | 0.2% | — | — | UNIT 12/09/2025 | G3710A121 |
| — | 5 01 ACQUISITION CORP | 500,000 | $4.925M | 0.2% | — | — | COM CL A | 33836P105 |
| — | RESEARCH ALLIANCE CORP II | 500,000 | $4.86M | 0.2% | — | — | COM CL A | 760873109 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 4,012,404 | $4.654M | 0.2% | — | — | COM NEW | 372427401 |
| CRVS | CORVUS PHARMACEUTICALS INC | 1,370,947 | $3.304M | 0.1% | — | — | COM | 221015100 |
| — | GALMED PHARMACEUTICALS LTD | 1,799,694 | $3.275M | 0.1% | — | — | SHS | M47238106 |
| — | ANGION BIOMEDICA CORP | 1,071,297 | $3.107M | 0.1% | — | — | COM | 03476J107 |
| — | ERYTECH PHARMA | 1,314,656 | $3.103M | 0.1% | — | — | SPONSORED ADR | 29604W108 |
| — | AILERON THERAPEUTICS INC | 5,265,555 | $2.964M | 0.1% | — | — | COM | 00887A105 |
| — | JIYA ACQUISITION CORP | 300,000 | $2.931M | 0.1% | — | — | COM CL A | 47760M102 |
| — | FORWARD PHARMA A/S | 432,892 | $2.584M | 0.1% | — | — | SPONSORD ADS NEW | 34986J204 |
| ABOS | ACUMEN PHARMACEUTICALS INC | 289,663 | $1.958M | 0.1% | — | — | COM | 00509G209 |
| — | X4 PHARMACEUTICALS INC | 847,879 | $1.942M | 0.1% | — | — | COM | 98420X103 |
| — | GENERATION BIO CO | 189,050 | $1.338M | 0.0% | — | — | COM | 37148K100 |
| — | BIONOMICS LIMITED | 80,971 | $1.016M | 0.0% | — | — | ADS | 09063M205 |
| RZLT | REZOLUTE INC | 190,815 | $912K | 0.0% | — | — | COM NEW | 76200L309 |
| VYGR | VOYAGER THERAPEUTICS INC | 22,200 | $60,000 | 0.0% | — | — | COM | 92915B106 |